Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 53 | OU2018 | Next issue

Obesity Update 2018

Obesity Update

A year in review: what are the highlights?

ea0053ou2 | A year in review: what are the highlights? | OU2018

Novel therapies for obesity – an update

Tan Tricia

Obesity surgery is not a scalable solution for obesity and diabetes. Options for pharmacotherapy are sorely required because there will be patients who cannot and will not have surgery, or perhaps will require a ‘bridge’ to surgery. Although oral agents such as Orlistat and Bupropion/Naltrexone are marketed in Europe, these treatments suffer from considerable side effects that limit their appeal and efficacy. Gut hormone treatments, exemplified by high-dose Liragluti...

ea0053ou3 | A year in review: what are the highlights? | OU2018

Metabolic surgery and mental health – what’s new

Scholtz Samantha

We review the year’s developments in the field of psychological support and assessment of patients undergoing metabolic surgery. In the move away from the gatekeeping role of the psychiatrist or psychologist within multi-disciplinary weight management teams, we review the evidence for psychological predictors of outcome after metabolic surgery. We review the long term psychological outcomes after metabolic surgery. There is a lack of parity of metabolic surgery being offe...